What is Ocular Therapeutix's book value per share?

Ocular Therapeutix (OCUL) reported book value per share of $2.60 in Q1 2026.

How has Ocular Therapeutix's book value per share changed year-over-year?

Ocular Therapeutix's book value per share increased by 65.3% year-over-year, from $1.57 to $2.60.

What is the long-term trend for Ocular Therapeutix's book value per share?

Over 5 years (2020 to 2025), Ocular Therapeutix's book value per share has grown at a 22.8% compound annual growth rate (CAGR), from $1.25 to $3.49.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ocular Therapeutix OCUL Book value per share

Book value per share at other companies

Regeneron PharmaceuticalsREGN

$291.77+10.4%

Bausch + LombBLCO

$17.96-0.4%

HRO

HarrowHROW

$0.77-51.1%

Tarsus Pharmaceuticals, Inc.TARS

$8.12-6.7%

Kodiak Sciences IncKOD

$1.81-12.2%

Ultragenyx PharmaceuticalRARE

-$2.35-257%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

total stockholders equity/weighted shares diluted=$2.60

Based on the most recent quarter.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's book value per share?: Ocular Therapeutix (OCUL) reported book value per share of $2.60 in Q1 2026.
How has Ocular Therapeutix's book value per share changed year-over-year?: Ocular Therapeutix's book value per share increased by 65.3% year-over-year, from $1.57 to $2.60.
What is the long-term trend for Ocular Therapeutix's book value per share?: Over 5 years (2020 to 2025), Ocular Therapeutix's book value per share has grown at a 22.8% compound annual growth rate (CAGR), from $1.25 to $3.49.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.